$2.99
-0.01-0.33%
Last update: Nov 11, 4:00 PM
Adicet Bio Inc
ACETNASDAQ
Adicet Bio fell 71.0% from $10.34 to $3.00, behind the S&P 500's +11.2%. Its worst day was Sep 28 (−29.6%), and its low came Nov 5 at $2.92.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Adicet Bio closed at its highest level of the year, 6.2% above where the year started.
+6.2% · S&P 500 +0.1%
Adicet Bio shares fell 17.2%, while the S&P 500 rose 0.1%.
−17.2% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
Adicet Bio shares fell 13.3%, while the S&P 500 fell 1.2%.
−13.3% · S&P 500 −1.2%
EPS of $-2.94 beat the $-3.08 estimate on $0.00 revenue (est. $2.9M).
+2.4% · S&P 500 −0.6%
Adicet Bio shares rose 13.1%, while the S&P 500 rose 0.8%.
+13.1%, the year's best day · S&P 500 +0.8%
EPS of $-1.88 beat the $-3.05 estimate on $0.00 revenue.
+4.2% · S&P 500 +0.8%
EPS of $-1.99 missed the $-1.79 estimate on $0.00 revenue.
−13.4% · S&P 500 −0.2%
Adicet Bio shares fell 12.3%, while the S&P 500 fell 0.5%.
−12.3% · S&P 500 −0.5%
Adicet Bio shares fell 29.6%, while the S&P 500 fell 0.7%.
−29.6%, the year's worst day, on 2M shares, the year's heaviest volume · S&P 500 −0.7%
EPS of $-1.76 missed the $-1.57 estimate on $0.00 revenue.
+4.5% · S&P 500 +0.3%
Where it ended: a close of $3.00 on Nov 10, 2026. Up next: Q4 2026 earnings on Mar 11, 2027 (EPS est. $-1.83).
Nothing in the past 12 months.
All ACET dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ACET and SPY from Benzinga historical bars. Not investment advice.
